ZUR-44934-95716
3 vaccinations
2 coded responses
34 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 006 / PR
- Registered
- 2021-11-18
- Relationship
- Child or adolescent in my care
- Guardian
- ACL-43454-58835
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-17
Dose 1 — Pfizer-BioNTech
-
2021-11-18
Registered in v-safe
-
2021-11-18
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-19
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-12-01
-
2021-12-08
Dose 2 — Pfizer-BioNTech
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-03-09
-
2022-06-08
Survey response — 6 months, dose 2, dependentMedDRA: Chills, Fatigue, Oropharyngeal pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: Sore throat, chills tirednessMedDRA releases: 2024-11 · check-in free text available
-
2022-12-10
Survey response — 12 months, dose 2, dependentMedDRA: Infection — Feeling: Good · Be unable to do your normal daily activitiesFree text: Through infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Dose 3 — Pfizer-BioNTech
-
2022-12-21
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain, Swelling · NoneAdult check-in
-
2022-12-22
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Swelling · NoneAdult check-in
- 2022-12-23
- 2022-12-25
- 2022-12-28
- 2023-01-04
- 2023-01-10
- 2023-01-17
- 2023-01-24
- 2023-01-31
- 2023-03-22
- 2023-06-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-17 | Pfizer-BioNTech | No |
| 2 | 2021-12-08 | Pfizer-BioNTech | No |
| 3 | 2022-12-20 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2, dependent
Symptoms: Sore throat, chills tiredness
Release 12 — 12 months, dose 2, dependent
Symptoms: Through infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Infection | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release